“Big Data”; application and use for the health system

by José Manuel Martínez Sesmero
Published 2015-01-01

Pre-exposure prophylaxis for the prevention of HIV infection: a new prevention paradigm?

by Javier Sánchez-Rubio Ferrández, José Manuel Martínez Sesmero
Published 2016-05-01

Development of a risk stratification model for pharmaceutical care in HIV patients

by Ramón Morillo-Verdugo, José Manuel Martínez-Sesmero, Alicia Lázaro-López, Javier Sánchez-Rubio, Herminia Navarro-Aznárez, Monike deMiguel-Cascón
Published 2017-05-01

Matching-Adjusted Indirect Comparisons in the assessment of hemato-oncological drugs

by Francisco Javier Parrondo-García, José Manuel Martínez-Sesmero, Javier De Castro-Carpeño, Araceli López-de las Heras, Alonso Fernández-Nistal
Published 2021-03-01

Perceptions about HIV pre-exposure prophylaxis among healthcare professionals in Spain (PERPPRES Study)

by Javier Sánchez-Rubio Ferrández, José Manuel Martínez Sesmero, Herminia Navarro Aznárez, Sergio Fernández Espínola, Ismael Escobar Rodríguez, José Manuel Ventura Cerdá
Published 2016-07-01

How Do Hospital Pharmacists Approach Substitution of Nanomedicines? Insights from a Qualitative Pilot Study and a Quantitative Market Research Analysis in Five European Countries

by Natalia Sofia, Stefan Mühlebach, Umberto M. Musazzi, Rani Khatib, José Manuel Martinez Sesmero, Hans-Peter Lipp, Jacqueline Surugue, Tiziana Di Francesco, Beat Flühmann
Published 2021-07-01

Cost-utility analysis of the fixed-dose combination of dolutegravir/abacavir/lamivudine as initial treatment of HIV+ patients in Spain

by Santiago Moreno Guillen, Juan Emilio Losa García, Juan Berenguer Berenguer, José Manuel Martínez Sesmero, Santiago Cenoz Gomis, Ruth Graefenhain, David Lopez Sanchez-Cambronero, Francisco Javier Parrondo Garcia
Published 2017-09-01